ABEO
Abeona Therapeutics Inc.Company with tickers: ABEO
CIK
318306
CUSIP
00289Y206
Shares Outstanding
56,995,144
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $8,720,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $9,555,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-23,033,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-17,075,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.30 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.30 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |